Documents
Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 300MG | 0 | ZIDOVUDINE | ZIDOVUDINE |
FDA Submissions
| ORIG | 1 | AP | 2010-10-27 | |
LABELING; Labeling | SUPPL | 5 | AP | 2012-10-25 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2020-02-07 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2020-02-07 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2020-02-07 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2020-02-07 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2020-02-07 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 1 |
SUPPL | 5 | Null | 1 |
SUPPL | 7 | Null | 7 |
SUPPL | 8 | Null | 15 |
SUPPL | 10 | Null | 7 |
SUPPL | 12 | Null | 7 |
SUPPL | 13 | Null | 7 |
TE Codes
CDER Filings
CIPLA
cder:Array
(
[0] => Array
(
[ApplNo] => 90561
[companyName] => CIPLA
[docInserts] => ["",""]
[products] => [{"drugName":"ZIDOVUDINE","activeIngredients":"ZIDOVUDINE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ZIDOVUDINE","submission":"ZIDOVUDINE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)